Abstract
Introduction: In this study, a precise, rapid and accurate ultra-performance liquid chromatography- tandem mass spectrometry (UPLC-MS/MS) method for the quantification of zhebeirine in mouse blood was developed, and pharmacokinetics of zhebeirine was studied for the first time after intravenous and oral administration.
Methods: The mobile phase consisted of acetonitrile-0.1% formic acid, with a flow rate at 0.4 mL/m during 4 min run time. MRM modes of m/z 414.5→81.0 for zhebeirine and m/z 430.2→412.2 for 3- dehydroverticine (internal standard) were utilized to perform quantitative analysis. Protein in mouse blood was directly precipitated with acetonitrile for sample preparation.
Results: The linear range was 1-3000 ng/mL with r>0.995, and LLOQ was 1 ng/mL. The intra-and inter-day precision of zhebeirine in mouse blood was less than 13%. The accuracy ranged from 91.2% to 112.5%, while the matrix effects were between 84.8% and 106.4%.
Conclusion: The UPLC-MS/MS was successfully applied to the pharmacokinetic study on zhebeirine after intravenous and oral administration, and the bioavailability was determined to be 22.8%.
Keywords: Zhebeirine, pharmacokinetics, bioavailability, mouse, UPLC-MS/MS, blood.
[http://dx.doi.org/10.1016/j.jfda.2016.10.003 ] [PMID: 29389572]
[http://dx.doi.org/10.3390/molecules22091402] [PMID: 28832506]
[http://dx.doi.org/10.1016/j.phymed.2011.12.010] [PMID: 22326548]
[http://dx.doi.org/10.1016/j.phymed.2015.12.016] [PMID: 26926170]
[http://dx.doi.org/10.3390/ijms12063770] [PMID: 21747705]
[http://dx.doi.org/10.1016/j.jep.2017.03.049] [PMID: 28359849]
[http://dx.doi.org/10.1007/s11101-016-9464-2]
[http://dx.doi.org/10.1556/1326.2017.00389]
[http://dx.doi.org/10.2174/1573412914666180501114659]
[http://dx.doi.org/10.1016/j.jpba.2019.02.023] [PMID: 30807917]
[http://dx.doi.org/10.1556/1326.2017.00365]
[http://dx.doi.org/10.1556/1326.2018.00415]
[http://dx.doi.org/10.1016/j.jchromb.2019.06.015] [PMID: 31207562]
[http://dx.doi.org/10.2174/1573412914666181011124515]
[http://dx.doi.org/10.1155/2018/1578643] [PMID: 29951541]
[http://dx.doi.org/10.1155/2018/1578643] [PMID: 30186850]
[http://dx.doi.org/10.2174/1573412912666160815115244]